Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Treatment Reviews|May 30, 2016
Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensusSimron Singh, Sylvia L Asa, Chris Dey, et al.Clinical Colorectal Cancer|November 13, 2018
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer-A UNICANCER GI-PRODIGE TrialJaafar Bennouna, Thierry André, Loïc Campion, et al.Current Oncology (Toronto, Ont.)|September 27, 2023
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023Essa Al-Mansor, Meghan Mahoney, Maxime Chenard-Poirier, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2018
A prospective intervention to improve happiness and reduce burnout in oncologistsMark Clemons, Sasha Mazzarello, Gregory Pond, et al.The New England Journal of Medicine|September 16, 2024
Ponsegromab for the Treatment of Cancer CachexiaJohn D Groarke, Jeffrey Crawford, Susie M Collins, et al.Clinical Colorectal Cancer|April 15, 2018
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group TrialDerek J Jonker, Patricia A Tang, Hagen Kennecke, et al.BMJ (Clinical Research Ed.)|September 13, 2022
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trialRebecca C Auer, Michael Ott, Paul Karanicolas, et al.JAMA Oncology|July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine TumorsSimron Singh, Lesley Moody, David L Chan, et al.Clinical Colorectal Cancer|November 25, 2023
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in CanadaWinson Y Cheung, Setareh Samimi, Kim Ma, et al.Current Oncology (Toronto, Ont.)|March 26, 2025
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024Jennifer Leigh, Arwa Ahmed, Francine Aubin, et al.Pageof 3